Search - tctmd.com

Displaying 481 - 500 of 3032

Sort: Relevancy | Date

Additional Case-Based Analysis and Procedure Examples

Presentation TCT 2023

Procedure – Edited Case & Post Redo-TAV CT findings

Presenter: Vinayak Bapat

October 25, 2023

Presentation TCT 2023

First Human Use of a ‘Hybrid’ (Polymer + Metal) Coronary Drug-Eluting Stent: The IonMAN Study

Presenter: Alexandre Abizaid

October 25, 2023

Presentation TCT 2023

A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study

Presenter: Stefan Verheye

October 25, 2023

Presentation TCT 2023

Case Presentation and CT Analysis – Step-by-step Using APP

Presenter: Miho Fukui

October 25, 2023

Presentation TCT 2023

Unified Terminology and Concepts

Presenter: Atsushi Okada

October 25, 2023

Presentation TCT 2023

Completeness of Revascularization by FFRCT: Association to Patient- and Vessel-Oriented Cardiac Outcomes

Presenter: Kristian Taekker Madsen

October 25, 2023

Presentation TCT 2023

Safety and Feasibility of Planning and Performing Coronary Artery Bypass Surgery Guided Solely by Coronary Computed Tomography Angiography

Presenter: Patrick Serruys

October 25, 2023

Presentation TCT 2023

TAV Designs and Compatibility

Presenter: Gilbert Tang

October 25, 2023

Presentation TCT 2023

Challenges in Redo TAV

Presenter: Toby Rogers

October 25, 2023

Presentation TCT 2023

Artificial Intelligence-Enabled Quantitative Plaque and Hemodynamic Analysis for Predicting Acute Coronary Syndrome Risk and Prevention Strategy: The EMERALD II Study

Presenter: Bon-Kwon Koo

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

Presentation TCT 2023

Highlife

Presenter: Nicolo Piazza

October 24, 2023

Presentation TCT 2023

Innovalve

Presenter: Chet Rihal

October 24, 2023

Presentation TCT 2023

AltaValve

Presenter: Marek Grygier

October 24, 2023

Presentation TCT 2023

Cephea

Presenter: Pradeep Yadav

October 24, 2023

Presentation TCT 2023

One-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results

Presenter: Firas Zahr

October 24, 2023

Presentation TCT 2023

TMVR Design Iteration and Patient Eligibility

Presenter: Juan Granada

October 24, 2023

Presentation TCT 2023

Are Outcome Trials Necessary for Renal Denervation Therapies?

Presenter: Ajay Kirtane

October 24, 2023

Presentation TCT 2023

LVOT Obstruction Prevention and Management

Presenter: Robert Lederman

October 24, 2023

Presentation TCT 2023

What Will the Next Trial Designs Look Like for Renal Denervation?

Presenter: Eric Secemsky

October 24, 2023

Advertisement

Procedure – Edited Case & Post Redo-TAV CT findings

First Human Use of a ‘Hybrid’ (Polymer + Metal) Coronary Drug-Eluting Stent: The IonMAN Study

A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study

Case Presentation and CT Analysis – Step-by-step Using APP

Unified Terminology and Concepts

Completeness of Revascularization by FFRCT: Association to Patient- and Vessel-Oriented Cardiac Outcomes

Safety and Feasibility of Planning and Performing Coronary Artery Bypass Surgery Guided Solely by Coronary Computed Tomography Angiography

TAV Designs and Compatibility

Challenges in Redo TAV

Artificial Intelligence-Enabled Quantitative Plaque and Hemodynamic Analysis for Predicting Acute Coronary Syndrome Risk and Prevention Strategy: The EMERALD II Study

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

Highlife

Innovalve

AltaValve

Cephea

One-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results

TMVR Design Iteration and Patient Eligibility

Are Outcome Trials Necessary for Renal Denervation Therapies?

LVOT Obstruction Prevention and Management

What Will the Next Trial Designs Look Like for Renal Denervation?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content